benefit

Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine

AGOURA HILLS, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano today…

2 weeks ago

Advanced Radiotherapy is a game-changer for India’s cancer care burden

MUMBAI, India, Nov. 27, 2025 /PRNewswire/ -- In a country with over 1.4 million[i] cases reported annually, with most being…

3 weeks ago

6G mobile networks will need up to three times today’s spectrum to meet surging data demands, new GSMA report shows.

Near-term government decisions to avoid future spectrum 'bottlenecks' are needed to benefit billions of consumers and businesses in a 6G…

4 weeks ago

Authors, Publishers, and Copyright Owners May Benefit from a $1.5 Billion Class Action Settlement

SEATTLE, Oct. 7, 2025 /PRNewswire/ -- JND Legal Administration A proposed class action settlement was reached in the lawsuit, Bartz v.…

2 months ago

TricorBraun Releases 2024 Sustainability Report

ST. LOUIS, Sept. 30, 2025 /PRNewswire/ -- Global packaging leader TricorBraun has released its 2024 Sustainability Report, detailing the company's continued…

3 months ago

Young voices drive SCO innovation and culture

BEIJING, Sept. 9, 2025 /PRNewswire/ -- A news report from China Daily: The Shanghai Cooperation Organization (SCO), guided by the…

3 months ago

Bybit TradFi Waives Fees on Stock CFDs and Index Trading

DUBAI, UAE, Sept. 8, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is pleased to enhance…

3 months ago

From Olympic glory to community impact: Sevran will welcome Paris 2024 pool

28 July 2025 - In the heart of Seine-Saint-Denis, one of Paris’s youngest and most under-resourced departments where half of the…

5 months ago

World Peace Concert SOUND OF PEACE: International Benefit Concert for Peace to Take Place for the First Time in Front of the Iconic St. Peter’s Square

ROME, July 21, 2025 /PRNewswire/ -- On the International Day of Peace, September 21, 2025, a historic event will take…

5 months ago

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer

PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN…

6 months ago